Ecopetrol
EC
Apple
AAPL
D.R. Horton
DHI
4
Meritage Homes
MTH
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
SNGX Soligenix
- 2.1500
- -0.0600-2.71%
Close Mar 31 16:00 ET
6.78MMarket Cap-0.43P/E (TTM)
2.2242High2.1300Low11.50KVolume2.1700Open2.2100Pre Close24.95KTurnover0.36%Turnover RatioLossP/E (Static)3.16MShares14.918452wk High1.65P/B6.78MFloat Cap1.830152wk Low--Dividend TTM3.15MShs Float719999.6400Historical High--Div YieldTTM4.26%Amplitude1.8300Historical Low2.1700Avg Price1Lot Size
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Soligenix Stock Forum
Soligenix Financial Results Reveal Widening Losses While Clinical Pipeline Expands
Can This New CTCL Treatment Outperform Current Standard of Care? Key Data Coming in March
🚀🚀🚀
Can this stock run like $Phio Pharmaceuticals (PHIO.US)$ and $Salarius Pharmaceuticals (SLRX.US)$ ?
EXCLUSIVE: Soligenix Tells Benzinga 'Study Supported by $2.6 Million FDA Orphan Products Development Grant'
Soligenix
Tells Benzinga HyBryte Expanded
Treatment Continues To Demonstrate Outcomes In -Early-Stage Cutaneous T-Cell Lymphoma
Tells Benzinga 'Patients have responded positively to HyBryte therapy, with over 70% (5 of the 6 subjects who have completed at least 18 weeks of therapy) already achieving "Treatment Success'
Soligenix's Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year
'Study Supported by $2.6 Million FDA Orphan Products Development...
No comment yet